4th Circ. Tosses Generic-Drug Injury Appeal Against Pliva

Law360, Los Angeles (January 28, 2014, 9:55 PM EST) -- The Fourth Circuit on Tuesday affirmed a lower court’s dismissal of claims brought against drugmaker Pliva Inc. for alleged injuries from using a generic version of the heartburn drug Reglan, holding that the district court didn’t abuse its discretion when denying the plaintiff leave to amend.

The three-judge appellate panel ruled that named plaintiff Arthur L. Drager, pursuing the appeal on behalf of now-deceased metoclopramide user Shirley Gross, couldn’t reverse a district court’s decisions in favor of Pliva. The appeals court rejected Drager’s argument that the...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.